OTCMKTS:HRIBF - Horiba Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $69.00 +7.97 (+13.06 %) (As of 07/19/2018 05:26 AM ET)Previous Close$69.00Today's Range$69.00 - $69.0052-Week Range$61.03 - $61.03Volume300 shsAverage Volume15 shsMarket Capitalization$2.93 billionP/E Ratio21.30Dividend YieldN/ABeta1.98 Company ProfileEarnings HistoryHeadlinesSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HORIBA, Ltd. provides a range of instruments and systems for automotive research and development, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing, metrology, and QC measurement applications. Its Automotive Test Systems segment offers emission measurement systems, emission analyzers, driveline test systems, engine and brake test systems, and drive recorders to the automotive, heavy-duty on/off-road, lawn and garden, marine, aerospace, locomotive, and recreational and utility vehicles. The company's Process & Environmental segment provides air pollution analyzers, stack gas analyzers, water quality analysis treatment and measurement systems, and environmental radiation monitors. Its HORIBA Medical segment designs, develops, and distributes diagnostic systems, such as hematology analyzers, clinical chemistry analyzers, and hybrid analyzers, as well as offers peri-analytical services for patients, doctors, private laboratories, clinics, and university hospitals. The company's Semiconductor segment provides mass flow controllers, pressure controllers, liquid source vaporization systems, plasma emission controllers, vacuum/gas monitors, gas generators, chemical concentration monitors, in-line pH monitors, ultra-pure water monitors, particle detection systems, plasma process monitors, and automatic refill systems to the semiconductor, FPD manufacturing process, and a range of other manufacturing processes. Its Scientific Instruments & Systems segment offers biomolecular analysis, molecular and microanalysis, surface and thin films characterization, particle characterization, elemental analysis, forensics, custom spectroscopy solutions, and spectroscopy and imaging products and services. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan. Receive HRIBF News and Ratings via Email Sign-up to receive the latest news and ratings for HRIBF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Analytical instruments Sub-IndustryN/A SectorIndustrial Products SymbolOTCMKTS:HRIBF CUSIPN/A WebN/A PhoneN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E Ratio21.30 Forward P/E Ratio14.35 P/E Growth1.43 Sales & Book Value Annual Sales$1.57 billion Price / Sales1.87 Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares42,530,000Market Cap$2,934.78 Horiba (OTCMKTS:HRIBF) Frequently Asked Questions What is Horiba's stock symbol? Horiba trades on the OTCMKTS under the ticker symbol "HRIBF." When is Horiba's next earnings date? Horiba is scheduled to release their next quarterly earnings announcement on Friday, August, 3rd 2018. View Earnings Estimates for Horiba. What is the consensus analysts' recommendation for Horiba? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Horiba in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of Horiba's key competitors? Some companies that are related to Horiba include Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO), Eyepoint Pharmaceuticals (EYPT), HTG Molecular Diagnostics (HTGM), Arrayit Corp common stock (ARYC) and Aethlon Medical (AEMD). Who are Horiba's key executives? Horiba's management team includes the folowing people: Mr. Atsushi Horiba, Chairman & Group CEO (Age 70)Mr. Juichi Saito, Exec. Vice Chairman & Group COO (Age 60)Dr. Masayuki Adachi, Pres, COO & DirectorMr. Sunao Kikkawa, Sr. Corp. Officer and Gen. Mang. of Fin. & Control DivisionMasao Okawa, Sr. Corp. Officer and Gen. Mang. of Gen. Admin. Division Has Horiba been receiving favorable news coverage? Headlines about HRIBF stock have trended somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Horiba earned a news sentiment score of 0.06 on Accern's scale. They also gave news stories about the company an impact score of 48.46 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term. How do I buy shares of Horiba? Shares of HRIBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Horiba's stock price today? One share of HRIBF stock can currently be purchased for approximately $69.00. How big of a company is Horiba? Horiba has a market capitalization of $2.93 billion and generates $1.57 billion in revenue each year. MarketBeat Community Rating for Horiba (OTCMKTS HRIBF)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 50 (Vote Outperform)Underperform Votes: 70 (Vote Underperform)Total Votes: 120MarketBeat's community ratings are surveys of what our community members think about Horiba and other stocks. Vote "Outperform" if you believe HRIBF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HRIBF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: What is the Book Value of a Share?